Page last updated: 2024-08-25

methotrexate and Cranial Nerve II Diseases

methotrexate has been researched along with Cranial Nerve II Diseases in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (71.43)	29.6817
2010's	1 (14.29)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Aldrees, S; Jeeva-Patel, T; Margolin, E	1
Oguzhan, O; Tayfun, B; Umur, KA	1
Foroozan, R; Maust, HA; Niazi, S; Savino, PJ; Sergott, RC; Weibel, S	1
Belohradsky, BH; Lohse, P; Stojanov, S; Weiss, M	1
Andreu, MA; Cassoux, N; Chapelon-Abric, C; Guilpain, P; Jaeger-Bizet, F; Le Thi Huong-Boutin, D; Lehoang, P; Nasica, X; Piette, JC; Wechsler, B	1
Clare, G; Colley, S; Elston, JS; Kennett, R	1
Andrei, S; Enache, V; Renetti, A; Spiroiu, C; Zemba, M; Zugravu, V	1

Reviews

1 review(s) available for methotrexate and Cranial Nerve II Diseases

Article	Year
Different ophthalmologic manifestations of sarcoidosis. Current opinion in ophthalmology, 2012, Volume: 23, Issue:6 Topics: Adult; Biopsy; Female; Horner Syndrome; Humans; Immunosuppressive Agents; Methotrexate; Optic Nerve Diseases; Pars Planitis; Sarcoidosis; Uveitis, Posterior	2012

Other Studies

6 other study(ies) available for methotrexate and Cranial Nerve II Diseases

Article	Year
Bilateral Infiltrative Optic Neuropathy of Systemic Mantle Cell Lymphoma. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020, Volume: 47, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Central Nervous System Neoplasms; Cytarabine; Fundus Oculi; Humans; Lymphoma, Mantle-Cell; Male; Methotrexate; Optic Nerve; Optic Nerve Diseases; Rituximab	2020
Use of methotrexate in sarcoid-associated optic neuropathy. Ophthalmology, 2003, Volume: 110, Issue:3 Topics: Adult; Female; Folic Acid Antagonists; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Optic Nerve Diseases; Prednisone; Sarcoidosis; Visual Acuity; Visual Fields	2003
A novel CIAS1 mutation and plasma/cerebrospinal fluid cytokine profile in a German patient with neonatal-onset multisystem inflammatory disease responsive to methotrexate therapy. Pediatrics, 2004, Volume: 114, Issue:1 Topics: Arthralgia; Carrier Proteins; Central Nervous System Diseases; Child; Chronic Disease; Cytokines; DNA Mutational Analysis; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammation; Male; Meningitis; Methotrexate; Mutation, Missense; NLR Family, Pyrin Domain-Containing 3 Protein; Optic Nerve Diseases; Syndrome; Urticaria	2004
[Bilateral optic neuropathy revealing systemic sarcoidosis]. La Revue de medecine interne, 2004, Volume: 25, Issue:10 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Blindness; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Optic Atrophy; Optic Nerve Diseases; Prednisone; Sarcoidosis; Time Factors	2004
Reversible optic neuropathy associated with low-dose methotrexate therapy. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2005, Volume: 25, Issue:2 Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Color Vision Defects; Evoked Potentials, Visual; Female; Folic Acid; Humans; Methotrexate; Optic Nerve Diseases; Scotoma; Visual Fields	2005
[Treatment of thyroid ophthalmopathy--a clinical case]. Oftalmologia (Bucharest, Romania : 1990), 2007, Volume: 51, Issue:1 Topics: Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Nicergoline; Optic Nerve Diseases; Risk Factors; Smoking; Treatment Outcome; Vasodilator Agents; Visual Field Tests; Vitamin B Complex	2007